TrialCNS drugs2013

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.

Amirhossein Modabbernia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.